share_log

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

11-K:员工持股年度报告
美股sec公告 ·  06/21 10:42
Moomoo AI 已提取核心信息
Novo Nordisk A/S, a global healthcare company, has filed its annual Form 11-K report with the U.S. Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report details the financial statements of the Novo Nordisk Puerto Rico 401(k) Plan, which is a defined contribution plan for the company's employees in Puerto Rico. The plan's net assets available for pension benefits saw a significant increase from $6,164,237 in 2022 to $8,264,238 in 2023. The report includes unaudited financial statements such as statements of net assets and changes in net assets available for pension benefits, along with notes to the financial statements. The plan's investments, which include mutual funds, common collective trusts, and Novo Nordisk A/S common stock...Show More
Novo Nordisk A/S, a global healthcare company, has filed its annual Form 11-K report with the U.S. Securities and Exchange Commission for the fiscal year ended December 31, 2023. The report details the financial statements of the Novo Nordisk Puerto Rico 401(k) Plan, which is a defined contribution plan for the company's employees in Puerto Rico. The plan's net assets available for pension benefits saw a significant increase from $6,164,237 in 2022 to $8,264,238 in 2023. The report includes unaudited financial statements such as statements of net assets and changes in net assets available for pension benefits, along with notes to the financial statements. The plan's investments, which include mutual funds, common collective trusts, and Novo Nordisk A/S common stock, are reported at fair value. The plan is exempt from the annual audit requirement due to having fewer than 100 participants and meets the conditions for an audit waiver under the Department of Labor’s Regulation. The plan's administrator is Novo Nordisk Inc., and Charles Schwab Trust Company serves as the trustee and custodian. The financial statements also note that the plan is in compliance with the Employee Retirement Income and Security Act of 1974 (ERISA) and the Puerto Rico Internal Revenue Code.
全球医药公司诺和诺德已向美国证券交易委员会提交了其截至2023年12月31日的财年度11-K表格报告。报告详细列出了诺和诺德波多黎哥401(k)计划的财务报表,该计划是为公司在波多黎哥的员工提供的一项确定性缴款计划。该计划的养老金可用净资产从2022年的$6,164,237增加至2023年的$8,264,238,该报告包括未经审计的财务报表,例如净资产陈述和可用于养老金福利的净资产变动,以及财务报表的注释。该计划的投资包括共同基金,普通集体信托和诺和诺德A/S普通股,按公允价值报告。该计划符合《雇员退休收入安全法》(ERISA)和波多黎哥国内税法。该计划的管理员是诺和诺德公司,嘉信信托公司充当受托人和管理员。
全球医药公司诺和诺德已向美国证券交易委员会提交了其截至2023年12月31日的财年度11-K表格报告。报告详细列出了诺和诺德波多黎哥401(k)计划的财务报表,该计划是为公司在波多黎哥的员工提供的一项确定性缴款计划。该计划的养老金可用净资产从2022年的$6,164,237增加至2023年的$8,264,238,该报告包括未经审计的财务报表,例如净资产陈述和可用于养老金福利的净资产变动,以及财务报表的注释。该计划的投资包括共同基金,普通集体信托和诺和诺德A/S普通股,按公允价值报告。该计划符合《雇员退休收入安全法》(ERISA)和波多黎哥国内税法。该计划的管理员是诺和诺德公司,嘉信信托公司充当受托人和管理员。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息